Intestinal permeability in patients with psoriasis

      This paper is only available as a PDF. To read, Please Download here.


      A possible relationship between intestinal structure and function in the pathogenesis of psoriasis has recently brought about considerable interest. The purpose of this study was to evaluate the intestinal permeability in psoriatic patients by comparing it with healthy controls. 15 psoriatic patients and 15 healthy volunteers entered the study. Intestinal permeability was evaluated using the 51Cr-labeled EDTA absorption test. The 24-h urine excretion of 51Cr-EDTA from psoriatic patients was 2.46 ± 0.81%. These results differed significantly from controls (1.95 ± 0.36%; P < 0.05). The difference in intestinal permeability between psoriatic patients and controls could be due to alterations in the small intestinal epithelium of psoriatics.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Dermatological Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Shuster S
        • Watson AJ
        • Marks J
        Small intestine in psoriasis.
        Br Med J. 1967; 3: 458-460
        • Bedi TR
        • Bhutani LK
        • Kandhari KC
        • Tandon BN
        Small bowel in skin diseases.
        Indian J Med Res. 1974; 62: 142-143
        • Hoede N
        • Morches B
        • Holzmann H
        Psoriasis. Eine Allgemeinerkrankung.
        Internist. 1974; 15: 186-191
        • Barry RE
        • Salmon PR
        • Read AE
        • Warin RP
        Mucosal architecture of the small bowel in case of psoriasis.
        Gut. 1971; 12: 873-877
        • Hendel L
        • Larsen JK
        • Ammitzboll T
        • Asboe-Hansen G
        A study of cell proliferation kinetics in the small intestinal epithelium of psoriasis patients.
        Clin Exp Dermatol. 1984; 9: 329-335
        • Bjarnason I
        • Peters TJ
        • Veall N
        A persistent defect in intestinal permeability in coeliac disease demonstrated by a 51Cr-labeled EDTA absorption test.
        Lancet. 1983; i: 323-325
        • Hughes S
        • Williams SE
        • Turnberg LA
        Crohn's disease and psoriasis.
        N Engl J Med. 1983; 308: 101
        • Yates VM
        • Watkinson G
        • Kelman A
        Further evidence for an association between psoriasis, Crohn's disease and ulcerative colitis.
        Br J Dermatol. 1982; 106: 323-330
        • Belew PW
        • Rosenberg EW
        • Skinner RB
        • Marley WM
        Endotoxemia in psoriasis.
        Arch Dermatol. 1982; 118: 142-143
        • Hall RP
        • Peck G
        • Lawley TJ
        Detection of IgA immune complexes in patients with psoriasis.
        Clin Res. 1981; 29: 597A
        • Gupta AK
        • Ellis CN
        • Siegel MT
        • Dwell EA
        • Griffiths CEM
        • Hamilton TA
        • Nicoloff BJ
        • Voorhees JJ
        Sulfasalazine improves psoriasis. A double-blind analysis.
        Arch Dermatol. 1990; 126: 487-493